*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Benefits and Risks of Prescribing Long-Term Use of Anticholinergic Agents in Schizophrenic Patients on Antipsychotics

Author: MAR’IYATUL ABD, RAFIDAH BAHARI
Abstract: Antipsychotics specifically the first-generation line of drugs is closely associated with the development of extrapyramidal side effects. Ever since its alleviating sequel was known, anticholinergic agents such as Artane and Procyclydine has been the mainstay therapeutic agent in combating the unwanted outcomes of antipsychotics use. Anticholinergics itself however has uninvited adverse effects of its own. Other than the uncontrollable central and peripheral side effects, there are studies to date which discovered the euphoric sensation experienced by anticholinergic consumers. As the attending physician, one must be aware of the benefits and risks of anticholinergics when prescribing such drugs to a mentally unwell patient.
Keyword: Schizophrenic Patients, Risks of Prescribing, Anticholinergics.
DOI: https://doi.org/10.31838/ijpr/2020.12.03.267
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free